Literature DB >> 29189177

Brain Cancer: Implication to Disease, Therapeutic Strategies and Tumor Targeted Drug Delivery Approaches.

Viral Shah1, Pratiksha Kochar1.   

Abstract

BACKGROUND: Cancer is one of the leading causes of morbidity and mortality worldwide. Brain cancer is identified as one of the most formidable forms of cancer due to several hurdles posed by the anatomy and physiology of the brain on the therapeutic strategies employed for treating brain cancer. Poor prognosis and high relapse rate further aggravate the situation leading to the high mortality rate in brain cancer.
OBJECTIVE: The present review gives a brief insight on different aspects of brain cancer by elucidating its types, causative factors, associated symptoms, diagnostic techniques, treatment strategies and limitations of current treatment strategies. The review summarizes novel drug delivery based treatment strategies for tumor targeting.
METHODS: Conventional surgical or chemotherapy based strategies are less efficient for treating brain cancer. Surgery is risky because extracting the tumors can permanently damage the brain and alter the patient's ability to function. Sometimes, surgery cannot be performed because of the anatomical location of the tumor which is beyond the reach or near to any vital region. Drug based therapy requires heavy doses to cross the blood brain barrier leading to systemic toxicity. The review summarizes fifteen different patented technologies for targeting the drug substance specifically to the tumor site in the brain. RESULT: Targeted drug delivery strategies serve as an efficient tool for treating brain cancer.
CONCLUSION: Novel strategies focused towards targeting drug substances specifically to brain tumor site would increase the therapeutic efficiency and reduce the toxicity of chemotherapeutics. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Blood brain barrier; brain cancer; chemotherapy; drug delivery to brain; treatment strategies; tumor targeting

Mesh:

Substances:

Year:  2018        PMID: 29189177     DOI: 10.2174/1574892812666171129142023

Source DB:  PubMed          Journal:  Recent Pat Anticancer Drug Discov        ISSN: 1574-8928            Impact factor:   4.169


  16 in total

1.  Stem Cell Extracellular Vesicles and their Potential to Contribute to the Repair of Damaged CNS Cells.

Authors:  Heather Branscome; Siddhartha Paul; Pooja Khatkar; Yuriy Kim; Robert A Barclay; Daniel O Pinto; Dezhong Yin; Weidong Zhou; Lance A Liotta; Nazira El-Hage; Fatah Kashanchi
Journal:  J Neuroimmune Pharmacol       Date:  2019-07-24       Impact factor: 4.147

2.  Evaluation of anti-glioma effects of benzothiazoles as efficient apoptosis inducers and DNA cleaving agents.

Authors:  Belgin Sever; Halilibrahim Ciftci
Journal:  Mol Cell Biochem       Date:  2022-10-11       Impact factor: 3.842

3.  Theranostic Potential of Adaptive Cold Atmospheric Plasma with Temozolomide to Checkmate Glioblastoma: An In Vitro Study.

Authors:  Vikas Soni; Manish Adhikari; Li Lin; Jonathan H Sherman; Michael Keidar
Journal:  Cancers (Basel)       Date:  2022-06-25       Impact factor: 6.575

Review 4.  Better Bioactivity, Cerebral Metabolism and Pharmacokinetics of Natural Medicine and Its Advanced Version.

Authors:  Jiaxi Xie; Cailing Zhong; Tingting Wang; Dan He; Luyang Lu; Jie Yang; Ziyi Yuan; Jingqing Zhang
Journal:  Front Pharmacol       Date:  2022-06-27       Impact factor: 5.988

Review 5.  The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?

Authors:  Mariana Medeiros; Marina Ferreira Candido; Elvis Terci Valera; María Sol Brassesco
Journal:  Cell Mol Life Sci       Date:  2021-07-31       Impact factor: 9.261

Review 6.  Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer.

Authors:  Brigitta Kis; Feng Chen Ifrim; Valentina Buda; Stefana Avram; Ioana Zinuca Pavel; Diana Antal; Virgil Paunescu; Cristina Adriana Dehelean; Florina Ardelean; Zorita Diaconeasa; Codruta Soica; Corina Danciu
Journal:  Int J Mol Sci       Date:  2019-11-25       Impact factor: 5.923

Review 7.  Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review.

Authors:  Fatima Ghandour; Alessio Squassina; Racha Karaky; Mona Diab-Assaf; Paola Fadda; Claudia Pisanu
Journal:  Brain Sci       Date:  2021-02-27

Review 8.  Molecular Imaging, How Close to Clinical Precision Medicine in Lung, Brain, Prostate and Breast Cancers.

Authors:  Zhaoguo Han; Mingxing Ke; Xiang Liu; Jing Wang; Zhengqi Guan; Lina Qiao; Zhexi Wu; Yingying Sun; Xilin Sun
Journal:  Mol Imaging Biol       Date:  2021-07-16       Impact factor: 3.488

9.  Income and Education Inequalities in Brain and Central Nervous System Cancer Incidence in Canada: Trends over Two Decades.

Authors:  Alysha Roberts; Min Hu; Mohammad Hajizadeh
Journal:  J Cancer Prev       Date:  2021-06-30

10.  The Association between Mortality-to-Incidence Ratios and Health Expenditures in Brain and Nervous System Cancers.

Authors:  Tsung-Han Lee; Wen-Wei Sung; Lung Chan; Hsiang-Lin Lee; Sung-Lang Chen; Yu-Hui Huang; Aij-Lie Kwan
Journal:  Int J Environ Res Public Health       Date:  2019-07-31       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.